NeuroSense Therapeutics Ltd. Number of Reportable Segments
NeuroSense Therapeutics Ltd. (NRSN) reported Number of Reportable Segments of 100.00% for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-03-31
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2025-12-31 | 100.00% 20-F · filed 2026-03-31 |